News

Watch Video from the World TB Day Congressional Briefing

World TB Day Congressional Briefing

Tuberculosis – We Can Beat this Global Killer

Wednesday, March 21, 2012

A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV. Special areas of focus of the briefing include US global leadership on TB, how communities are addressing the crisis, the threat of drug-resistant TB, and progress towards an effective vaccine, better medications and faster diagnostics.

Moderator: John Fawcett, Legislative Director, RESULTS Educational Fund

Video Part One: http://youtu.be/fJsVfAlS2VM

Video Part Two: http://youtu.be/v0n4ruQEp1M

Video Part Three: http://youtu.be/tiUIEA-RtgA

Speakers:

Ariel Pablos-Mendez, Assistant Administrator for Global Health at the U.S. Agency for International Development (USAID)

US Partnership in Advancing the Response to TB

Powerpoint: http://youtu.be/c9QHAldjAhg

__________________________________________________________

Carol Nyirenda, Executive Director of the Community Initiative for Tuberculosis ( TB), HIV/AIDS and Malaria plus related diseases (CITAM +), Zambia

African Leadership at all Levels Confronting TB and TB-HIV

Powerpoint: http://youtu.be/B4x9FVt2hRQ

__________________________________________________________

Jennifer Woolley, Director of Advocacy, Aeras

New Tools for TB: Investing in Long-Term Solutions

Powerpoint: http://youtu.be/8ydSujoNxlA

__________________________________________________________

Dr. Lucica Ditiu, Executive Secretary, Stop TB Partnership

US leadership is crucial in winning the TB battle

Powerpoint: http://youtu.be/EbjRHCMJ228

Co-sponsored by RESULTS Educational Fund, American Thoracic Society, Stop TB Partnership, Aeras, and Treatment Action Group

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...